Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 17;2(4):650-654.
doi: 10.1016/j.jaccao.2020.06.012. eCollection 2020 Nov.

How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain: A Single Center Approach

Affiliations
Review

How to Diagnose and Manage Patients With Fluoropyrimidine-Induced Chest Pain: A Single Center Approach

Allison Padegimas et al. JACC CardioOncol. .
No abstract available

Keywords: 5-FU, 5-fluorouracil; CAD, coronary artery disease; CTA, computed tomography angiogram; CV, cardiovascular; FLOX, bolus dosing 5 fluorouracil, leucovirin, oxaliplatin; FOLFOX, continuous infusion 5 fluorouracil, leucovorin, oxaliplatin; cardiotoxicity; coronary vasospasm; fluoropyrimidine.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Diffuse ST-Segment Elevation From Coronary Vasospasm Electrocardiogram showing diffuse ST-segment elevation during bolus 5-fluorouracil administration attributed to coronary artery vasospasm.
Figure 2
Figure 2
Fluoropyrimidine Cardiac Toxicity and Rechallenge Various cardiac toxicities from fluoropyrimidines, distinct chest pain syndromes attributable to specific agents, and appropriate treatment and/or diagnostic steps. We outline an algorithm using anti-anginal administration for safe fluoropyrimidine rechallenge. ∗According to blood pressure. AMI = acute myocardial infarction; CAD = coronary artery disease CCB = calcium channel blocker; CTA = computed tomography angiography; ECG = electrocardiogram; ER = extended release; 5-FU = 5-fluorouracil.

References

    1. Jaskanwal D.S., Kaur J., Khodadadi R. 5-fluorourcil and cardiotoxicity: a review. Therap Adv Med Oncol. 2018;10:1–18. - PMC - PubMed
    1. Focaccetti C., Bruno A., Magnani E. Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ROS production in endothelial cells and cardiomyocytes. PLoS One. 2015;10 - PMC - PubMed
    1. Polk A., Vistisen K., Vaage-Nilsen M., Nielsen D.L. A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity. BMC Pharmacol Toxicol. 2014;15:47. - PMC - PubMed
    1. Yuan C., Parekh H., Allegra C. 5-FU induced cardiotoxicity: case series and review of the literature. Cardiooncology. 2019;5:3. - PMC - PubMed
    1. Polk A., Shahmarvandis N.N., Vistisen K. Incidence and risk-factors for capecitabine-induced symptomatic cardiotoxicity: a retrospective study of 452 consecutive patients with metastatic breast cancer. BMJ Open. 2016;6 - PMC - PubMed

LinkOut - more resources